Lindsay A Md Rosenwald is Director of AVENUE THERAPEUTICS, INC.. Currently has a direct ownership of 354,318 shares of ATXI, which is worth approximately $793,672. The most recent transaction as insider was on Sep 08, 2023, when has been sold 348,675 shares (Common Stock) at a price of $0.72 per share, resulting in proceeds of $251,046. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 354K
0% 3M change
0% 12M change
Total Value Held $793,672

LINDSAY A MD ROSENWALD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 08 2023
BUY
Open market or private purchase
$251,046 $0.72 p/Share
348,675 Added 49.6%
354,318 Common Stock

Also insider at

CKPT
Checkpoint Therapeutics, Inc. Healthcare
FBIO
Fortress Biotech, Inc. Healthcare
DERM
Journey Medical Corp Healthcare
MBIO
MUSTANG BIO, INC. Healthcare
LAM

Lindsay A Md Rosenwald

Director
Scottsdale, AZ

Track Institutional and Insider Activities on ATXI

Follow AVENUE THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATXI shares.

Notify only if

Insider Trading

Get notified when an Avenue Therapeutics, Inc. insider buys or sells ATXI shares.

Notify only if

News

Receive news related to AVENUE THERAPEUTICS, INC.

Track Activities on ATXI